223018
Retinoic acid
98%
Synonym(s):
ATRA, Tretinoin, Vitamin A acid, all-trans-Retinoic acid
Sign Into View Organizational & Contract Pricing
All Photos(1)
About This Item
Recommended Products
Assay
98%
mp
180-181 °C (lit.)
SMILES string
CC1=C(\C=C\C(C)=C\C=C\C(C)=C\C(O)=O)C(C)(C)CCC1
InChI
1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+
InChI key
SHGAZHPCJJPHSC-YCNIQYBTSA-N
Gene Information
human ... RARA(5914) , RARB(5915) , RARG(5916)
Looking for similar products? Visit Product Comparison Guide
Application
Antitumor agent and inducing factor in leukemia differentiation.
Biochem/physiol Actions
all−trans−Retinoic acid (ATRA) is a ligand for both the retinoic acid receptor (RAR) and the retinoid X receptor (RXR). The bound RAR and RXR act as transcription factors that regulate the growth and differentiation of both normal and malignant cells. Cytochromes P450 (CYPs) catalyze the 4-hydroxylation of ATRA. Retinoic acid primes embryonic stem cells to become neurons.
Ligand for both the retinoic acid receptor (RAR) and the retinoid X receptor (RXR); primes embryonic stem cells to become neurons.
replaced by
Product No.
Description
Pricing
Regulatory Information
新产品
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Cellular and Molecular Biology, 40, 297-297 (1994)
Anti-cancer drug design, 8(4), 299-322 (1993-08-01)
Differentiation therapy focuses on the development and use of specific agents designed to selectively engage the process of terminal differentiation, leading to the eventual elimination of tumorigenic cells and rebalance of normal cellular homeostasis. Extensive in vitro study of the
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service